Gene: MUC5AC
Official Full Name: mucin 5AC, oligomeric mucus/gel-formingprovided by HGNC
Gene Summary: Predicted to enable extracellular matrix constituent, lubricant activity. Predicted to be an extracellular matrix structural constituent. Predicted to act upstream of or within maintenance of lens transparency. Located in extracellular space and mucus layer. Implicated in dry eye syndrome. Biomarker of several diseases, including Sjogren's syndrome; biliary tract disease (multiple); cystic fibrosis; eye disease (multiple); and pancreatic cancer (multiple). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09491 | MUC5AC Knockout cell line (A549) | Human | MUC5AC | 1:3~1:4 | Negative | Online Inquiry |
KO39179 | MUC5AC Knockout cell line (HeLa) | Human | MUC5AC | 1:3~1:6 | Negative | Online Inquiry |
MUC5AC Gene Knockout Cell Lines represent a transformative tool for researchers investigating the role of mucins, specifically MUC5AC, in various biological processes and disease mechanisms. These cell lines are engineered to have a specific deletion of the MUC5AC gene, allowing for the study of mucin function in cellular environments without the confounding effects typically observed in wild-type cells. This meticulous gene editing is facilitated through CRISPR-Cas9 technology, ensuring precise knockout of the target gene.
The MUC5AC gene encodes a major gel-forming mucin, which plays a critical role in the formation of mucus in the respiratory and gastrointestinal tracts. By utilizing these knockout cell lines, researchers can explore the molecular pathways influenced by MUC5AC, including its involvement in inflammation, tissue repair, and mucus hypersecretion associated with chronic diseases like asthma and cystic fibrosis. The cell lines serve as a powerful model for studying the pathophysiology of these conditions, providing insights into potential therapeutic targets.
One of the standout features of the MUC5AC Gene Knockout Cell Lines is their specific applicability in drug discovery and the validation of mucin-targeted therapies. Compared to standard cell lines, these knockout models provide a more accurate representation of mucin-related diseases, thus enhancing the translational potential of research findings into clinical applications. The elimination of MUC5AC allows for the elucidation of compensatory mechanisms and the testing of novel treatments devoid of unexpected mucin-related effects.
Furthermore, the availability of these specialized cell lines is a substantial advantage for both academic and pharmaceutical laboratories aiming to expedite their research processes. By providing a clear experimental framework to dissect mucin biology, these knockout cell lines empower researchers to derive robust conclusions with confidence.
Our company prides itself on delivering cutting-edge biological products that bridge the gap between discovery and application. With extensive expertise in genetic engineering and cell line development, we are committed to supporting the scientific community with high-quality tools like the MUC5AC Gene Knockout Cell Lines, designed to propel research forward and ultimately improve patient outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.